SYNDAX PHARMACEUTICALS
Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor, in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor. Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.
SYNDAX PHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2005-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.syndax.com
Total Employee:
101+
Status:
Active
Contact:
(185) 879-2799
Email Addresses:
[email protected]
Total Funding:
803.58 M USD
Technology used in webpage:
Domain Not Resolving Google Font API Google Google Cloud JQuery CDN Vimeo Google Cloud Global Multi-Region New Relic Mobile Optimized Drupal
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Syndax Pharmaceuticals
AI Life Sciences Investments LLC
AI Life Sciences Investments LLC investment in Post-IPO Debt - Syndax Pharmaceuticals
Boxer Capital
Boxer Capital investment in Post-IPO Debt - Syndax Pharmaceuticals
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Debt - Syndax Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Debt - Syndax Pharmaceuticals
OrbiMed
OrbiMed investment in Series C - Syndax Pharmaceuticals
RMI Partners
RMI Partners investment in Series C - Syndax Pharmaceuticals
BioMed Ventures
BioMed Ventures investment in Series C - Syndax Pharmaceuticals
Delos Capital
Delos Capital investment in Series C - Syndax Pharmaceuticals
Tavistock Life Sciences
Tavistock Life Sciences investment in Series C - Syndax Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.syndax.com Semrush global rank: 1.98 M Semrush visits lastest month: 10.69 K
Unable to get host informations!!!
More informations about "Syndax Pharmaceuticals"
About Us - Syndax
At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. We believe that it takes a community to build a great medicine, and that is why we are working to set the new standard for …See details»
Career Opportunities - Syndax
Do Not Sell or Share my Personal Information. © 2025 Syndax PharmaceuticalsSee details»
Events & Presentations - Syndax Pharmaceuticals, Inc.
Syndax Third Quarter 2021 Conference Call. 11.15.21 / 4:30 PM EST. Listen to webcast. View Presentation 1 MB. Syndax Pharmaceuticals Axatilimab Collaboration Conference Call. …See details»
Syndax Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. Syndax Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Syndax Pharmaceuticals is a …See details»
Syndax Announces Changes to its Board of Directors
Their contributions and insights as Syndax continues its efforts to advance its innovative pipeline of cancer therapies and evolve into a commercial organization.” Mr. Podlesak added, “ On behalf …See details»
Syndax - Org Chart, Teams, Culture & Jobs - The Org
View Syndax's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Investors | Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include …See details»
Syndax Pharmaceuticals Management Team | Org Chart
Top Syndax Pharmaceuticals Management Employees Michael Metzger Chief Executive Officer and Director at Syndax Pharmaceuticals New York, NY, US View. 1 syndax.com; 5+ …See details»
Syndax Pharmaceuticals Org Chart + Executive Team - The Official …
Organizational Chart of Syndax Pharmaceuticals. Syndax Pharmaceuticals Org Chart www.syndax.com. has 16 executives +1 781 419 1400; Add an executive. Syndax …See details»
Syndax Pharmaceuticals Inc Company Profile - Overview
Syndax Pharmaceuticals Inc (Syndax) is a commercial-stage biopharmaceutical company that discovers, develops, and commercializes therapies for multiple cancer indications. The …See details»
Syndax Reports Fourth Quarter and Full Year 2024 Financial …
Mar 3, 2025 Our early results are consistent with the high unmet need in R/R KMT2A-rearranged acute leukemia and reflect strong execution across our entire organization,” said Michael A. …See details»
Syndax Pharmaceuticals Restructures Leadership Team
Dec 20, 2024 Syndax Pharmaceuticals operates in the biotechnology industry, focusing on developing therapies for cancer treatment. YTD Price Performance: -40.54% Average Trading …See details»
Mission, Vision & Core Values of Syndax Pharmaceuticals
Dec 19, 2024 At the core of our organization lies a commitment to integrity, collaboration, and relentless pursuit of progress, driving us to make a lasting impact in the fight against cancer. …See details»
SyndAccess Resources & Support — Patient & Family Support
Please see Full Prescribing Information, including BOXED WARNING.. Medical Support. To report an adverse event or product quality complaint for a Syndax medication, or to request …See details»
Careers - Syndax
Careers - SyndaxSee details»
Syndax Mission, Benefits, and Work Culture | Indeed.com
Come see what’s going on inside Syndax, including the company culture, employee work-life benefits, and business goals. Discover all the key insights that make people want to work …See details»
SyndAccess Support Program for Syndax Medications
SyndAccess is here to answer your questions and provide support for you or your loved one throughout your time on Syndax medications. Get support from a SyndAccess nurse. Call 1 …See details»
What is Syndax Pharmaceuticals? Company Culture, Mission, Values
At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a clinical stage biopharmaceutical …See details»
SyndAccess — Support for Your Patient's Syndax Journey
SyndAccess provides dedicated support for eligble patients prescribed a Syndax medication. Our resources help with Access, Affordability, and Adherence. Download Enrollment Form Call …See details»
Syndax Pharmaceuticals Reports First Quarter 2024 Financial …
May 8, 2024 Mr. Closter brings to Syndax more than 30 years of commercial experience in the biopharmaceutical industry. First Quarter 2024 Financial Results. As of March 31, 2024, …See details»